Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy

Diabetic retinopathy (DR) is a leading cause of irreversible blindness globally. Qidengmingmu Capsule (QC) is a Chinese patent medicine used to treat DR, but the molecular mechanism of the treatment remains unknown. In this study, we identified and validated potential molecular mechanisms involved i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mingxu, Yang, Jiawei, Zhao, Xiulan, Zhao, Ying, Zhu, Siquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016862/
https://www.ncbi.nlm.nih.gov/pubmed/33795817
http://dx.doi.org/10.1038/s41598-021-86914-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016862/
https://www.ncbi.nlm.nih.gov/pubmed/33795817
http://dx.doi.org/10.1038/s41598-021-86914-8

Ejemplares similares